Skip to content
★ Sign in to follow
DB

Diane Barrett

Noven Pharmaceuticals Inc
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (19 ops.)
€1.3M

Latest filing published 09 Feb 2007 for NOVEN PHARMACEUTICALS INC, €9,070.

Insider track record

Disclosed buys
0
Disclosed sells
19
Signal history

No signal scores available.

Diane Barrett: trading record in brief

Diane Barrett discloses dealings in Noven Pharmaceuticals Inc to SEC (Form 4). The record holds 26 filings, for trades running from 12 September 2006 to 7 February 2007.

The open-market record consists of 19 sales worth €1.3M, with no purchase. The rest of the record consists of 7 option exercises. 2007 to date brings no purchases and 2 sales.

On 9 February 2007 came the latest disclosure, an option exercise for €9,070 in Noven Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Diane Barrett

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    11,812 USD0SEC
    901 shares@ US$13.11Common Stock ($.0001 par value)SEC:0001209191-07-009139:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    25,048 USD0SEC
    901 shares@ US$27.80Common Stock ($.0001 par value)SEC:0001209191-07-009139:1
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    131,100 USD0SEC
    10,000 shares@ US$13.11Common Stock ($.0001 par value)SEC:0001209191-07-005821:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    268,000 USD0SEC
    10,000 shares@ US$26.80Common Stock ($.0001 par value)SEC:0001209191-07-005821:1
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    125,400 USD0SEC
    12,000 shares@ US$10.45Common Stock ($.0001 par value)SEC:0001209191-06-064604:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    63,625 USD0SEC
    2,500 shares@ US$25.45Common Stock ($.0001 par value)SEC:0001209191-06-064604:1
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    50,900 USD0SEC
    2,000 shares@ US$25.45Common Stock ($.0001 par value)SEC:0001209191-06-064604:2
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    63,500 USD0SEC
    2,500 shares@ US$25.40Common Stock ($.0001 par value)SEC:0001209191-06-064604:3
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    63,475 USD0SEC
    2,500 shares@ US$25.39Common Stock ($.0001 par value)SEC:0001209191-06-064604:4
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    63,300 USD0SEC
    2,500 shares@ US$25.32Common Stock ($.0001 par value)SEC:0001209191-06-064604:5
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    128,478 USD0SEC
    9,800 shares@ US$13.11Common Stock ($ .0001 par value)SEC:0001209191-06-054576:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    243,040 USD0SEC
    9,800 shares@ US$24.80Common Stock ($ .0001 par value)SEC:0001209191-06-054576:1
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    2,622 USD0SEC
    200 shares@ US$13.11Common Stock ($ .0001 par value)SEC:0001209191-06-052953:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    4,962 USD0SEC
    200 shares@ US$24.81Common Stock ($ .0001 par value)SEC:0001209191-06-052953:1
  • ◇
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    250,800 USD0SEC
    24,000 shares@ US$10.45Common Stock ($.0001 par value)SEC:0001209191-06-050002:0
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    36,390 USD0SEC
    1,500 shares@ US$24.26Common Stock ($.0001 par value)SEC:0001209191-06-050002:1
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    60,725 USD0SEC
    2,500 shares@ US$24.29Common Stock ($.0001 par value)SEC:0001209191-06-050002:2
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    60,825 USD0SEC
    2,500 shares@ US$24.33Common Stock ($.0001 par value)SEC:0001209191-06-050002:3
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    60,875 USD0SEC
    2,500 shares@ US$24.35Common Stock ($.0001 par value)SEC:0001209191-06-050002:5
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    60,925 USD0SEC
    2,500 shares@ US$24.37Common Stock ($.0001 par value)SEC:0001209191-06-050002:6
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    61,000 USD0SEC
    2,500 shares@ US$24.40Common Stock ($.0001 par value)SEC:0001209191-06-050002:7
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    61,150 USD0SEC
    2,500 shares@ US$24.46Common Stock ($.0001 par value)SEC:0001209191-06-050002:8
  • ▼
    VP & Chief Financial OfficerExecutivesNoven Pharmaceuticals Inc
    122,850 USD0SEC
    5,000 shares@ US$24.57Common Stock ($.0001 par value)SEC:0001209191-06-050002:9

23 of 23 declarations